European University of Madrid

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

President of the Madrid Medical Association, Professor of Medicine at the European University of Madrid, and Head of the Cardiology Department at Gregorio Marañón Hospital

Contents related to this centre
Adobe Stock

The HORIZON trial was the first to evaluate the potential effect on cardiovascular risk of a drug—pelacarsen—that reduces lipoprotein(a) levels in the blood. While this approach had generated high expectations, it did not prove successful in this trial, which involved 8,000 patients who had already experienced cardiovascular events. The negative results, which Novartis previewed in a press release in September, are being presented in full on November 7 at the American Heart Association congress and are published in NEJM.

Walking

A team from China used data from over 17,000 people in the UK Biobank to analyze the relationship between physical activity and cardiovascular risk. Their results indicate that the current minimum recommendation of 150 minutes of moderate-to-vigorous physical activity per week was associated with an 8-9% risk reduction. However, increasing the time to 560-610 minutes was linked to a decrease of more than 30%. According to the authors, who published the study in the British Journal of Sports Medicine, the current recommendations offer universal but modest protection, and optimal benefits would be obtained with substantially higher levels of activity.